Stoke Therapeutics (STOK) Interest Coverage Ratio (2025 - 2026)

Stoke Therapeutics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 2322.52 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio fell 102.09% year-over-year to 2322.52; the TTM figure through Mar 2026 stood at 165.25 (down 436.62% YoY), while the FY2025 annual figure was 0.11, up 97.75% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 2322.52, down from 56.16 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 111240.0 in Q1 2025, with the low at 14363.67 in Q3 2025.
• The 5-year median for Interest Coverage Ratio is 26.96 (2022), against an average of 5440.8.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio tumbled 71336.33% in 2024, then soared 8725.69% in 2025.
• Stoke Therapeutics' Interest Coverage Ratio stood at 0.28 in 2022, then rose by 20.05% to 0.22 in 2023, then slumped by 7858.15% to 17.66 in 2024, then plunged by 217.96% to 56.16 in 2025, then tumbled by 4035.55% to 2322.52 in 2026.
• Business Quant data shows STOK's Interest Coverage Ratio at 2322.52 in Q1 2026, 56.16 in Q4 2025, and 14363.67 in Q3 2025.